Figure 3.

Study profile

The primary analysis was done in the primary population who had Plasmodium vivax monotherapy and with the exclusion of malaria recurrences. Mixed infection was P vivax and P falciparum. G6PD=glucose-6-phosphate dehydrogenase. *An unanticipated temporary stockout of G6PD tests caused by international supply issues required the suspension of treatment algorithm implementation in some facilities in Porto Velho and withdrawal of tafenoquine. Patients treated during this time were excluded to maintain the integrity of the analysis.